CorePlus and Ibex show real world success with AI for routine cancer diagnosis.
CorePlus and Ibex show real world success with AI for routine cancer diagnosis
Published on January 5, 2024Publications
- ArteraAI, a developer of AI-based cancer tests, has partnered with CorePlus, a CLIA-certified pathology laboratory in Puerto Rico.Publications
- Insights into the shift from manual microscopy to digital diagnostics using Techcyte's AI platform.Videos
CorePlus partners with Alpenglow Biosciences and positions itself as a leader in the new era of 3D pathologyThe innovation will enable pathologists to improve accuracy in diagnosing prostate cancer.Press Releases